Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection

Yao-Hsu Yang, Yu-Hui Huang, Ya-Hui Chuang, Chung-Min Peng, Li-Chieh Wang, Yu-Tsan Lin, Bor-Luen Chiang, Yao-Hsu Yang, Yu-Hui Huang, Ya-Hui Chuang, Chung-Min Peng, Li-Chieh Wang, Yu-Tsan Lin, Bor-Luen Chiang

Abstract

The severe acute respiratory syndrome (SARS) is caused by infection with the SARS-associated coronavirus (SARS-CoV) and characterized by severe pulmonary inflammation and fibrosis. In this study, the development of autoantibodies against human epithelial cells and endothelial cells in patients with SARS at different time periods (the first week: phase I, 1 month after the disease onset: phase II/phase III) were investigated. Antibodies in sera of patients and healthy controls against: (1) A549 human pulmonary epithelial cell-line, (2) human umbilical venous endothelial cells (HUVEC), (3) primary human pulmonary endothelial cells (HPEC) were detected by cell-based ELISA and indirect immunofluorescence staining. The results revealed that serum levels of IgG anti-A549 cells antibodies, IgG anti-HUVEC antibodies, and IgM anti-HPEC antibodies were significantly higher in SARS patients at phase II/phase III than those in healthy controls. Sera from SARS patients at phase II/phase III could mediate complement dependent cytotoxicity against some A549 cells and HPEC. It is concluded that some autoantibodies against human epithelial cells and endothelial cells would be developed after SARS-CoV infection and this phenomenon may indicate post-infectious cellular injury and also induce SARS-induced immunopathology.

(c) 2005 Wiley-Liss, Inc.

References

    1. Ablin RJ. 1972. Antiepithelial antibodies in prostatic cancer. Arch Dermatol 105: 759.
    1. Beijing Group of National Research Project for SARS . 2003. Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome. Chin Med J (Engl) 116: 1283–1287.
    1. Bordron A, Revelen R, D'Arbonneau F, Dueymes M, Renaudineau Y, Jamin C, Youinou P. 2001. Functional heterogeneity of anti‐endothelial cell antibodies. Clin Exp Immunol 124: 492–501.
    1. Cacoub P, Ghillani P, Revelen R, Thibault V, Calvez V, Charlotte F, Musset L, Youinou P, Piette JC. 1999. Anti‐endothelial cell auto‐antibodies in hepatitis C virus mixed cryoglobulinemia. J Hepatol 31: 598–603.
    1. Carvalho D, Savage CO, Isenberg D, Pearson JD. 1999. IgG anti‐endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell‐derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 42: 631–640.
    1. Chiang CH, Chen HM, Shih JF, Su WJ, Perng RP. 2003. Management of hospital‐acquired severe acute respiratory syndrome with different disease spectrum. J Chin Med Assoc 66: 328–338.
    1. Colon JE, Bhol KC, Razzaque MS, Ahmed AR. 2001. In vitro organ culture model for mucous membrane pemphigoid. Clin Immunol 98: 229–234.
    1. Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, Cai J, Li X, Kang W, Weng D, Lu Y, Wu D, He L, Yao K. 2003. The clinical pathology of severe acute respiratory syndrome (SARS): A report from China. J Pathol 200: 282–289.
    1. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967–1976.
    1. Fowler RA, Lapinsky SE, Hallett D, Detsky AS, Sibbald WJ, Slutsky AS, Stewart TE, Toronto SARS Critical Care Group . 2003. Critically ill patients with severe acute respiratory syndrome. JAMA 290: 367–373.
    1. Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, Selbs E, McEvoy CP, Hayden CD, Fukuoka J, Taubenberger JK, Travis WD. 2003. Lung pathology of severe acute respiratory syndrome (SARS): A study of 8 autopsy cases from Singapore. Hum Pathol 34: 743–748.
    1. Grunebaum E, Blank M, Cohen S, Afek A, Kopolovic J, Meroni PL, Youinou P, Shoenfeld Y. 2002. The role of anti‐endothelial cell antibodies in Kawasaki disease—in vitro and in vivo studies. Clin Exp Immunol 130: 233–240.
    1. Ho JC, Ooi GC, Mok TY, Chan JW, Hung I, Lam B, Wong PC, Li PC, Ho PL, Lam WK, Ng CK, Ip MS, Lai KN, Chan‐Yeung M, Tsang KW. 2003. High‐dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 168: 1449–1456.
    1. Jaffe EA, Nachman RL, Becker CG, Minick RC. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745–2756.
    1. Lang Z, Zhang L, Zhang S, Meng X, Li J, Song C, Sun L, Zhou Y. 2003. Pathological study on severe acute respiratory syndrome. Chin Med J (Engl) 116: 976–980.
    1. Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH, Lee S, Bang D. 2003. Human alpha‐enolase from endothelial cells as a target antigen of anti‐endothelial cell antibody in Behcet's disease. Arthritis Rheum 48: 2025–2035.
    1. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. 2003. Angiotensin‐converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426: 450–454.
    1. Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH, Lin YS. 2003. Antibodies from dengue patient sera cross‐react with endothelial cells and induce damage. J Med Virol 69: 82–90.
    1. Lindquist KJ, Osterland CK. 1971. Human antibodies to vascular endothelium. Clin Exp Immunol 9: 753–760.
    1. Meroni PL, Khamashta MA, Youinou P, Shoenfeld Y. 1995. Mosaic of anti‐endothelial antibodies. Review of the first international workshop on anti‐endothelial antibodies: Clinical and pathological significance. Lupus 4: 95–99.
    1. Ng PC, Lam CW, Li AM, Wong CK, Cheng FW, Leung TF, Hon EK, Chan IH, Li CK, Fung KS, Fok TF. 2004. Inflammatory cytokine profile in children with severe acute respiratory syndrome. Pediatrics 113: e7–e14.
    1. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY, HKU/UCH SARS Study Group . 2003a. Clinical progression and viral load in a community outbreak of coronavirus‐associated SARS pneumonia: A prospective study. Lancet 361: 1767–1772.
    1. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY, SARS study group . 2003b. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361: 1319–1325.
    1. Poon LL, Chan KH, Wong OK, Cheung TK, Ng I, Zheng B, Seto WH, Yuen KY, Guan Y, Peiris JS. 2004. Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real‐time quantitative reverse transcription‐PCR assays. Clin Chem 50: 67–72.
    1. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. 2001. Classification of anti‐endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implications. Arthritis Rheum 44: 1484–1494.
    1. Snook JA, Lowes JR, Wu KC, Priddle JD, Jewell DP. 1991. Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis. Gut 32: 163–166.
    1. Sun A, Hsieh RP, Liu BY, Wang JT, Leu JS, Wu YC, Chiang CP. 2000. Strong association of antiepithelial cell antibodies with HLA‐DR3 or DR7 phenotype in patients with recurrent oral ulcers. J Formos Med Assoc 99: 290–294.
    1. Tan EM, Pearson CM. 1972. Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum 15: 23–28.
    1. Toyoda M, Petrosian A, Jordan SC. 1999. Immunological characterization of anti‐endothelial cell antibodies induced by cytomegalovirus infection. Transplantation 68: 1311–1318.
    1. Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan‐Yeung M, Lam WK, Seto WH, Yam LY, Cheung TM, Wong PC, Lam B, Ip MS, Chan J, Yuen KY, Lai KN. 2003. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 48: 1977–1985.
    1. Twu SJ, Chen TJ, Chen CJ, Olsen SJ, Lee LT, Fisk T, Hsu KH, Chang SC, Chen KT, Chiang IH, Wu YC, Wu JS, Dowell SF. 2003. Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis 9: 718–720.
    1. Worda M, Sgonc R, Dietrich H, Niederegger H, Sundick RS, Gershwin ME, Wick G. 2003. In vivo analysis of the apoptosis‐inducing effect of anti‐endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum 4: 2605–2614.
    1. Yang YH, Wang SJ, Chuang YH, Lin YT, Chiang BL. 2002. The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF‐alpha treatment in children with Henoch–Schonlein purpura. Clin Exp Immunol 130: 352–357.
    1. Yeh SH, Wang HY, Tsai CY, Kao CL, Yang JY, Liu HW, Su IJ, Tsai SF, Chen DS, Chen PJ, Chen DS, Lee YT, Teng CM, Yang PC, Ho HN, Chen PJ, Chang MF, Wang JT, Chang SC, Kao CL, Wang WK, Hsiao CH, Hsueh PR. 2004. Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: Molecular epidemiology and genome evolution. Proc Natl Acad Sci USA 101: 2542–2547.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere